BACKGROUND: Increasing patient cost sharing is a commonly employed mechanism to contain health care expenditures. OBJECTIVE: To explore whether the impact of increases in prescription drug copayments differs between high- and low-income areas. DESIGN: Using a database of 6 million enrollees with employer-sponsored health insurance, econometric models were used to examine the relationship between changes in drug copayments and adherence with medications for the treatment of diabetes mellitus (DM) and congestive heart failure (CHF). SUBJECTS: Individuals 18 years of age and older meeting prespecified diagnostic criteria for DM or CHF were included. MEASUREMENTS: Median household income in the patient's ZIP code of residence from the 2000 Census was used as the measure of income. Adherence was measured by medication possession ratio: the proportion of days on which a patient had a medication available. RESULTS: Patients in low-income areas were more sensitive to copayment changes than patients in high- or middle-income areas. The relationship between income and price sensitivity was particularly strong for CHF patients. Above the lowest income category, price responsiveness to copayment rates was not consistently related to income. CONCLUSIONS: The relationship between medication adherence and income may account for a portion of the observed disparities in health across socioeconomic groups. Rising copayments may worsen disparities and adversely affect health, particularly among patients living in low-income areas.
BACKGROUND: Increasing patient cost sharing is a commonly employed mechanism to contain health care expenditures. OBJECTIVE: To explore whether the impact of increases in prescription drug copayments differs between high- and low-income areas. DESIGN: Using a database of 6 million enrollees with employer-sponsored health insurance, econometric models were used to examine the relationship between changes in drug copayments and adherence with medications for the treatment of diabetes mellitus (DM) and congestive heart failure (CHF). SUBJECTS: Individuals 18 years of age and older meeting prespecified diagnostic criteria for DM or CHF were included. MEASUREMENTS: Median household income in the patient's ZIP code of residence from the 2000 Census was used as the measure of income. Adherence was measured by medication possession ratio: the proportion of days on which a patient had a medication available. RESULTS:Patients in low-income areas were more sensitive to copayment changes than patients in high- or middle-income areas. The relationship between income and price sensitivity was particularly strong for CHFpatients. Above the lowest income category, price responsiveness to copayment rates was not consistently related to income. CONCLUSIONS: The relationship between medication adherence and income may account for a portion of the observed disparities in health across socioeconomic groups. Rising copayments may worsen disparities and adversely affect health, particularly among patients living in low-income areas.
Authors: Douglas W Roblin; Richard Platt; Michael J Goodman; John Hsu; Winnie W Nelson; David H Smith; Susan E Andrade; Stephen B Soumerai Journal: Med Care Date: 2005-10 Impact factor: 2.983
Authors: R Tamblyn; R Laprise; J A Hanley; M Abrahamowicz; S Scott; N Mayo; J Hurley; R Grad; E Latimer; R Perreault; P McLeod; A Huang; P Larochelle; L Mallet Journal: JAMA Date: 2001 Jan 24-31 Impact factor: 56.272
Authors: Sebastian Schneeweiss; Stephen B Soumerai; Robert J Glynn; Malcolm Maclure; Colin Dormuth; Alexander M Walker Journal: CMAJ Date: 2002-03-19 Impact factor: 8.262
Authors: Joshua S Benner; Robert J Glynn; Helen Mogun; Peter J Neumann; Milton C Weinstein; Jerry Avorn Journal: JAMA Date: 2002 Jul 24-31 Impact factor: 56.272
Authors: Nancy Krieger; Pamela Waterman; Jarvis T Chen; Mah-Jabeen Soobader; S V Subramanian; Rosa Carson Journal: Am J Public Health Date: 2002-07 Impact factor: 9.308
Authors: Natalia Mena-Vazquez; Sara Manrique-Arija; Lucía Yunquera-Romero; Inmaculada Ureña-Garnica; Marta Rojas-Gimenez; Carla Domic; Francisco Gabriel Jimenez-Nuñez; Antonio Fernandez-Nebro Journal: Rheumatol Int Date: 2017-06-19 Impact factor: 2.631
Authors: Vicki Fung; Mary Reed; Mary Price; Richard Brand; William H Dow; Joseph P Newhouse; John Hsu Journal: Health Serv Res Date: 2013-05-13 Impact factor: 3.402
Authors: Walid F Gellad; Niteesh K Choudhry; Mark W Friedberg; M Alan Brookhart; Jennifer S Haas; William H Shrank Journal: Health Serv Res Date: 2008-11-04 Impact factor: 3.402
Authors: Maria Pisu; Joshua Richman; Kendra Piper; Roy Martin; Ellen Funkhouser; Chen Dai; Lucia Juarez; Jerzy P Szaflarski; Edward Faught Journal: Med Care Date: 2017-07 Impact factor: 2.983
Authors: Nirav R Shah; Annemarie G Hirsch; Christopher Zacker; Scott Taylor; G Craig Wood; Walter F Stewart Journal: J Gen Intern Med Date: 2008-12-17 Impact factor: 5.128